Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 13/2017

01-12-2017 | Gastrointestinal Oncology

“Total Mesenteric Peritonectomy for Peritoneal Metastases” (with Video) by Jean-Baptiste Cazauran et al.

Author: Paul H. Sugarbaker, MD, FACS, FRCS

Published in: Annals of Surgical Oncology | Issue 13/2017

Login to get access

Excerpt

Early successes in the management of peritoneal metastases were based on preventing cancer implants that often resulted after the resection of a primary gastrointestinal cancer. The first reports of benefit, coming from Japan, involved gastric cancer with serosal invasion,1 or cytology-positive gastric cancer.2 …
Literature
1.
Yan TD, Black D, Sugarbaker PH, Zhu J, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.CrossRefPubMed
2.
Coccolini F, Catena F, Glehen O, Yonemura Y, et al. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer: systematic review and meta-analysis. Eur J Surg Oncol. 2016;42:1261–7.CrossRefPubMed
3.
Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61:232–7.CrossRefPubMed
4.
Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89:480–7.CrossRefPubMed
5.
6.
De Lima Vazquez V, Sugarbaker PH. Cholecystectomy, lesser omentectomy, and stripping of the omental bursa, a peritonectomy procedure. J Surg Oncol. 2003;84:45–49.CrossRef
7.
Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2007;14:2281–8.CrossRefPubMed
8.
Bijelic L, Sugarbaker PH. Cytoreduction of the small bowel surfaces. J Surg Oncol. 2008;97:176–9.CrossRefPubMed
9.
Deraco M, Baratti D, Kusamura S, et al. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100(4):321–8.CrossRefPubMed
10.
Sugarbaker PH, van der Speeten K. An overview of peritonectomy, visceral resections, and therapeutic laparoscopy for peritoneal surface malignancy. In: Sugarbaker PH (ed) Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. 2nd ed. Cine-Med Publishing, Woodbury, 2017, pp 17–46.
11.
Metadata
Title
“Total Mesenteric Peritonectomy for Peritoneal Metastases” (with Video) by Jean-Baptiste Cazauran et al.
Author
Paul H. Sugarbaker, MD, FACS, FRCS
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6100-3

Other articles of this Issue 13/2017

Annals of Surgical Oncology 13/2017 Go to the issue

Bone and Soft Tissue Sarcomas

Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival

Translational Research and Biomarkers

Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer

Reconstructive Oncology

Microsurgical Reconstruction Following Oncologic Resection in Pediatric Patients: A 15-Year Experience

Gastrointestinal Oncology

Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis

Bone and Soft Tissue Sarcomas

Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis

Bone and Soft Tissue Sarcomas

Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303